食品科学

• 营养卫生 • 上一篇    下一篇

酪蛋白糖巨肽对二甲肼干预的大鼠细胞因子网络变化的研究

陈庆森,王金凤,阎亚丽,庞广昌   

  1. 1.天津市食品生物技术重点实验室,天津商业大学生物技术与食品科学学院,天津 300134;
    2.北京时合生物科技有限公司,北京 100176
  • 出版日期:2014-07-15 发布日期:2014-07-18

Effects of Casein Glycomacropeptide on Dimethyl Hydrazine-Induced Alteration of Cytokine Network in Rats

CHEN Qing-sen, WANG Jin-feng, YAN Ya-li, PANG Guang-chang   

  1. 1. Tianjin Key Laboratory of Food Biotechnology, College of Biotechnology and Food Science, Tianjin University of Commerce,
    Tianjin 300134, China; 2. Beijing Shihe Biological Technology Co. Ltd., Beijing 100176, China
  • Online:2014-07-15 Published:2014-07-18

摘要:

目的:探讨不同剂量酪蛋白糖巨肽(casein glycomacropeptide,CGMP)干预二甲肼处理的大鼠时,外周血和结肠组织内细胞因子水平的变化情况,从而推断CGMP对二甲肼处理的大鼠细胞因子网络的影响。方法:60 只Wistar雄性大鼠随机分为正常组、模型组、CGMP低剂量组、CGMP中剂量组和CGMP高剂量组。除正常组外,对每只大鼠每周腹腔注射二甲肼,剂量为30 mg/(kg•周),同时,3 个剂量CGMP组注射二甲肼的同时每天灌胃CGMP,剂量分别为10、50、100 mg/(kg•d)。15 周后,处死大鼠,取其结肠组织和血清,首先检测结肠末端异型隐窝灶个数,然后利用液相芯片法检测结肠组织和血清中的细胞因子的表达水平。结果:乳源CGMP对大鼠体质量影响没有显著性差异,乳源CGMP对大鼠内毒素和活性氧簇的水平具有显著的抑制作用,其抑制作用呈剂量依赖趋势。乳源CGMP可显著抑制异型隐窝灶的形成,且异型隐窝灶个数呈剂量依赖性降低。乳源CGMP可以显著抑制大鼠体内Th1/Th2类细胞因子的失衡,且呈剂量依赖趋势。结论:乳源CGMP具有改善二甲肼处理的大鼠结肠组织损伤的功能,其机制为乳源CGMP可以有效抑制二甲肼处理的大鼠体内异型隐窝灶的形成,并呈剂量依赖性,研究显示乳源CGMP可以下调大鼠体内IL-4等Th2类细胞因子的异常升高,促进IL-2等Th1类细胞因子的分泌,改善大鼠体内处于失衡状态的细胞因子网络。

关键词: 乳源酪蛋白糖巨肽, 细胞因子网络, 异型隐窝灶

Abstract:

Purpose: In order to infer the influence of casein glycomacropeptide (CGMP) on the cytokine network in rats treated
with dimethyl hydrazine, we studied the changes in cytokines in peripheral blood and colon of rats challenged with intraperitoneal
injection of dimethyl hydrazine, followed by intragastric administration of different doses of CGMP. Methods: A total of 60 Wistar
rats were randomly divided into five groups: normal, model, low dose CGMP, moderate dose CGMP and high dose CGMP groups.
The rats from all other groups except for the normal group were injected weekly with dimethyl hydrazine at 30 mg/kg bw. At
the same time, the rats in the low-, moderate- and high dose-CGMP groups were orally administered daily with CGMP at 10, 50
and 100 mg/(kg·d), respectively. Fifteen weeks later, the rats were killed and colon and serum samples were taken. The number
of colon aberrant crypt foci was counted, and the levels of cytokines in colon and peripheral blood were detected by using the
Luminex assay. Results: 1) no significant difference in body weight in rats among CGMP-treated and control groups was seen
whereas CGMP significantly reduced the levels of endotoxin and reactive oxygen species in a dose-dependent manner; 2) CGMP
significantly inhibited the formation of aberrant crypt foci (ACF) in a dose-dependent manner; 3) CGMP significantly inhibited
imbalance of Th1/Th2 cytokines in rats treated with dimethyl hydrazine in a dose-dependent manner. Conclusions: CGMP could
improve colon damage in rats treated with dimethyl hydrazine by effectively inhibiting the formation of ACF in a dose-dependent
manner, downregulating the levels of Th2 cytokines such as IL-4, and promoting the secretion of Th1 cytokines such as IL-2 to
improve the imbalance of the cytokine network.

Key words: casein glycomacropeptide (CGMP), cytokine network, aberrant crypt foci(ACF)